Skip to main content
Login
Contact
Subscribe
Search form
Search
The Sweetwater Reporter
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Photos
Videos
Games
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Ampio Pharmaceutical
(NY:
AMPE
)
0.5100
USD
UNCHANGED
Streaming Delayed Price
/ Updated:
8:00 PM EST, Jan 18, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
0.5000 (177)
Ask (Size)
0.5135 (5)
Prev. Close
0.5100
Today's Range
0.5100 - 0.5100
52wk Range
0.3500 - 3.890
Shares Outstanding
86,320,968
Dividend Yield
N/A
Performance
YTD
+15.91%
+15.91%
1 Month
+18.60%
+18.60%
3 Month
+15.88%
+15.88%
6 Month
-83.00%
-83.00%
1 Year
-82.41%
-82.41%
Top News
More News
Ampio Updates Regulatory Status for Ampion
December 13, 2018
Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today updates the regulatory status of Ampion.
Read More
from
PR Newswire
Ampio Updates Regulatory and Publication status for Ampion™
November 26, 2018
Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today updates the regulatory and peer-review publication status of Ampion.
Read More
from
PR Newswire
More News
Read More
Ampio Updates Regulatory and Clinical Status for Ampion™
November 07, 2018
from
PR Newswire
Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Ampio Pharmaceuticals, Inc. (AMPE) and Encourages AMPE Investors to Contact the Firm
October 30, 2018
from
GlobeNewswire News Releases
Factors of Influence in 2018, Key Indicators and Opportunity within Intersect ENT, Akari Therapeutics, Ampio Pharmaceuticals, Virtusa, Umpqua, and Hamilton Lane — New Research Emphasizes Economic Grow
October 25, 2018
from
GlobeNewswire News Releases
SHAREHOLDER ALERT: AMPE LCI PZZA SKX PM USAT COCP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
October 23, 2018
from
GlobeNewswire News Releases
WEDNESDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Fir
October 23, 2018
from
GlobeNewswire News Releases
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMPE, OPK, QRTEA and HTHT
October 22, 2018
from
GlobeNewswire News Releases
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pinduoduo, CV Sciences, and Ampio and Encourages Investors to Contact the Firm
October 21, 2018
from
GlobeNewswire News Releases
SHAREHOLDER ALERT: AMPE NVRO PZZA OPK QRTEA MCHP COCP TGTX CPB TRVN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
October 21, 2018
from
GlobeNewswire News Releases
AMPE OCT. 24 ALERT: Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors of Important Deadline in First Filed Case Commenced by Firm – AMPE
October 20, 2018
from
GlobeNewswire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
